ATLAS fair value
ATLAS has no fair value for this stock today.
Neogen Chemicals share price today, ATLAS forecast and fair value
Basic Materials · Specialty Chemicals · National Stock Exchange of India · India
Prices as of Oct 26, 2026 · INR
ATLAS has no fair value for this stock today.
49%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Neogen Chemicals a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹1,998 and ₹2,351; in 9 out of 10, between ₹1,730 and ₹2,715. Estimated annual volatility is 48%.
ATLAS does not publish a fair value for NEOGEN.NSE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks NEOGEN.NSE has traded between ₹966.70 and ₹2,785. Today it is 21.9% below that high and 125% above its low.
On the business: net margin is 3.8%; it trades at 163.5 times earnings.
Its beta is 0.73: it tends to move less than the market.
Neogen Chemicals Ltd. is a specialty chemicals manufacturer based in India, focusing primarily on the production and sale of bromine and lithium-based compounds.
Want to see everything about Neogen Chemicals?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Neogen Chemicals Ltd. is a specialty chemicals manufacturer based in India, focusing primarily on the production and sale of bromine and lithium-based compounds.
49%: close to a coin flip. In half of the simulated outcomes, NEOGEN.NSE ends the month between ₹1,998 and ₹2,351.
Neogen Chemicals's market capitalization is ₹74.6B. Its price-to-earnings (P/E) ratio is 163.5: you pay ₹163.5 for each ₹1.00 of yearly earnings.
Yes. NEOGEN.NSE's current dividend yield is 0.18% at today's price (₹2,175).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy